scholarly journals Curbing sweet cravings

2011 ◽  
Vol 13 (1) ◽  
pp. 2-2
Author(s):  
Monica Hoyos Flight
Keyword(s):  
Sweet Cravings

scholarly journals 187 Buprenorphine/Naloxone (Suboxone and Bunavail)-Induced Glycolimia, an Indication of Undermedication?

CNS Spectrums ◽  
2018 ◽  
Vol 23 (1) ◽  
pp. 107-107 ◽  
Author(s):  
Stefany Kress ◽  
Alan Hirsch
Keyword(s):  
Reward System ◽  
Opiate Dependence ◽  
Opiate Withdrawal ◽  
White Female ◽  
Compensatory Response ◽  
Insulin Dependent ◽  
Typical Day ◽  
High Doses ◽  
Sweet Cravings ◽  
The Brain

AbstractINTRODUCTIONBuprenorphine/Naloxone combination drugs such as Suboxone and Bunavail have not been reported to induce glycolimia. Two such cases are presented.METHODSCASE STUDY: Case 1: A 30-year-old, right-handed, white female with a history of opioid abuse was started on 4.2 mg buprenorphine/0.7 mg naloxone (Bunavail) BID and began sweet cravings and consumption of sweet foods. In a typical day she would eat 16 strawberry pop-tarts and 2 boxes of Little Debbie cookies. This may have provoked the 10 pound weight augmentation in the first two weeks of treatment. She denied any craving for opioids and no evidence of opioid withdrawal was present. Her Clinical Opiate Withdrawal Scale (COWS) score =4 (normal).Case 2: A 51-year-old, right-handed, male with opiate dependence, four days following the initiation of Suboxone (8 mg buprenorphine/2 mg naloxone) BID, developed strong cravings for sugary foods including donuts and ice cream, of which he was previously never inclined to eat and gained 10 pounds in one month. His COWS score= 7 (mild symptoms).DISCUSSIONThere are myriad mechanisms that may be acting to induce sugar cravings with buprenorphine/naloxone. Humans and rats acutely withdrawing from opiates, such as heroin, develop strong urges for consumption of sugary substances (Lieblich et al., 1991; Sapira, 1968; Weiss, 1982). Glycolimia in the above cases may reflect early or subclinical withdrawal, which if becoming more severe, would manifest as opioid craving. If the value of the reward system induced by sweets doesn’t meet the threshold invoked by the opioid stimulation, this “withdrawal” may lead to further sugar cravings in an attempt to reach the same reward level. In animals, certain foods and drugs share the same neurological pathway involved in the “reward system” potentially explaining why opioids influence food palatability in humans (Pelchat, 2002).Alternatively, it is possible that buprenorphine induces hypoglycemia at high doses (Bullingham et al., 1981) such that hypoglycemia may paradoxically act to enhance sugar craving similar to the Somogyi effect in insulin dependent diabetics. Another possible mechanism of action is that since buprenorphine acts to decrease glucose metabolism in the brain (Walsh et al., 1994), this may lead to a neural compensatory response by increasing sugar access to the brain behaviorally via glycolimiaand somatically reducing insulin release, thus explaining the high hemoglobin A1c observed in opioid addicts (Giugliano, 1984). Given the above presentation, complaints of sugar craving may indicate consideration to increase buprenorphine dosing and trial of this in those with glycolimia without opioid dependence may be warranted.Funding AcknowledgementsNo funding.

scholarly journals Changes in Food Cravings and Eating Behavior after a Dietary Carbohydrate Restriction Intervention Trial

Nutrients ◽  
2019 ◽  
Vol 12 (1) ◽  
pp. 52 ◽  
Author(s):  
Katherene O.-B. Anguah ◽  
Majid M. Syed-Abdul ◽  
Qiong Hu ◽  
Miriam Jacome-Sosa ◽  
Colette Heimowitz ◽  
...  
Keyword(s):  
Eating Behavior ◽  
Eating Behaviors ◽  
Dietary Restraint ◽  
Time Frame ◽  
Restricted Diet ◽  
High Fat ◽  
Food Cravings ◽  
Before And After ◽  
Sweet Cravings ◽  
Fat Diets

Compared to low-fat diets, low-carbohydrate (CHO) diets cause weight loss (WL) over a faster time frame; however, it is unknown how changes in food cravings and eating behavior contribute to this more rapid WL in the early phases of dieting. We hypothesized that reductions in food cravings and improved eating behaviors would be evident even after a relatively short (4-week) duration of CHO-restriction, and that these changes would be associated with WL. Adult participants (n = 19, 53% males, mean ± SD: BMI = 34.1 ± 0.8 kg/m2; age 40.6 ± 1.9 years) consumed a CHO-restricted diet (14% CHO, 58% fat, 28% protein) for 4 weeks. Before and after the intervention, specific and total cravings were measured with the Food Craving Inventory (FCI) and eating behaviors assessed with the Three-Factor Eating questionnaire. Food cravings were significantly reduced at week 4, while women had significantly greater reductions in sweet cravings than men. Dietary restraint was significantly increased by 102%, while disinhibiton and hunger scores were reduced (17% and 22%, respectively, p < 0.05). Changes in cravings were unrelated to changes in body weight except for the change in high-fat cravings where those who lost the most weight experienced the least reductions in fat cravings (r = −0.458, p = 0.049). Changes in dietary restraint were inversely related to several FCI subscales. A short-term, low-CHO diet was effective in reducing food cravings. These data suggest that in subjects that have successfully lost weight on a low-CHO diet, those who craved high-fat foods at the onset were able to satisfy their cravings—potentially due to the high-fat nature of this restricted diet.

scholarly journals Long-Term Modulation of Appetitive Hormones and Sweet Cravings After Adjustable Gastric Banding and Roux-en-Y Gastric Bypass

2019 ◽  
Vol 29 (11) ◽  
pp. 3698-3705 ◽  
Author(s):  
Alina I. Tsouristakis ◽  
Gerardo Febres ◽  
Donald J. McMahon ◽  
Beverly Tchang ◽  
Irene M. Conwell ◽  
...  
Keyword(s):  
Gastric Bypass ◽  
Gastric Banding ◽  
Adjustable Gastric Banding ◽  
Sweet Cravings

Sweet Cravings and Alzheimer's Disease

1991 ◽  
Vol 39 (5) ◽  
pp. 535-536 ◽  
Author(s):  
Gisele P. Wolf-Klein ◽  
Felix A. Silverstone ◽  
Arnold P. Levy
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Sweet Cravings

scholarly journals Recombinant Human Leptin Does Not Alter Gut Hormone Levels after Gastric Bypass but May Attenuate Sweet Cravings

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Rushika Conroy ◽  
Gerardo Febres ◽  
Donald J. McMahon ◽  
Michael O. Thorner ◽  
Bruce D. Gaylinn ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Gastric Bypass ◽  
Gut Hormones ◽  
Liquid Meal ◽  
Gut Hormone ◽  
Sweet Cravings ◽  
The Impact ◽  
To Receive ◽  
Reduced State

Bariatric surgery improves glucose homeostasis and alters gut hormones partly independent of weight loss. Leptin plays a role in these processes; levels are decreased following bariatric surgery, creating a relative leptin insufficiency. We previously showed that leptin administration in a weight-reduced state after Roux-en-Y gastric bypass (RYGB) caused no further weight loss. Here, we discuss the impact of leptin administration on gut hormones, glucostasis, and appetite. Weight stable women after RYGB were randomized to receive placebo or recombinant human metreleptin (0.05 mg/kg twice daily). At weeks 0 and 16, a liquid meal challenge was performed. Glucose, insulin, C-peptide, GLP-1, PYY, glucagon, and ghrelin (total, acyl, and desacyl) were measured fasting and postprandially. Appetite was assessed using a visual analog scale. Mean post-op period was53±2.3months; mean BMI was34.6±0.2 kg/m2. At 16 weeks, there was no significant change in weight within or between groups. Fasting PYY was significantly different between groups and the leptin group had lower sweets craving at week 16 than the placebo group (P<0.05). No other differences were observed. Leptin replacement does not alter gut hormones or glucostasis but may diminish sweet cravings compared to placebo in this population of post-RYGB women.

Sign in / Sign up

Export Citation Format

Share Document